Homework Exercise

1 / 21

# Homework Exercise - PowerPoint PPT Presentation

Homework Exercise. ACCT 70311 . Question 1 (a). Calculate expected enterprise income, RNEA, and residual enterprise income for each year, 2014 – 2019 under GAAP accounting (where R&amp;D expenditures are expensed against income). Question 1(a). Expected enterprise income. Question 1(a).

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.

## PowerPoint Slideshow about 'Homework Exercise' - tamra

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

### Homework Exercise

ACCT 70311

Question 1 (a)
• Calculate expected enterprise income, RNEA, and residual enterprise income for each year, 2014 – 2019 under GAAP accounting (where R&D expenditures are expensed against income)
Question 1(a)
• Expected enterprise income
Question 1(a)
• Expected RNEA
Question 1(a)
• Expected residual income
Question 1(b)
• Now calculate the RNEA and residual enterprise income for each year under he accounting regime that capitalized R&D expenditures and amortizes them over five years
Question 1(b)
• Residual enterprise income
Question 1(c)
• Why are RNEA and residual enterprise income for each year different under the two accounting treatments?
• Two major differences:
• Under the capitalization approach, deferring depreciation results in a higher EPAT in early years, which favorably affects RNEA and REI
• Under the expense approach, large R&D amortization expenses do not occur, which allows for greater RNEA and REI in later years
Question 1(d)
• Forecast RNEA for 2020 under the two accounting treatments
Question 1(d)
• Forecast REI for 2020 under the two accounting treatments
Question 1(d)
• Why do RNEA and REI forecasts differ for 2020?
• Forecasts differ because each approach has reached an equivalent steady state for EPAT, but NEA is larger for the capitalized approach because unamortized prior years’ R&D is included as an asset
Question 1(e)
• Value the firm at the end of 2013 using the two different accounting treatments
• Each approach yields same value
• They have each reached steady state
Question 1(f)
• If you tried to value this firm by forecasting only to 2016, what difficulties would you face under the two methods?
• Steady state would not be reached
• REI model would not yield an accurate valuation
Question 1(g)
• When R&D is expensed, RNEA is higher despite sales growing at a slower rate in 2016 – 2018 and decreasing in 2019 for two reasons:
• R&D expenses are decreasing
• Sales are higher than pre-2016 years because more revenue is being generated from the investment in R&D (earlier investments plus current investment)
Question 2(a)
• EPAT and NEA under 3y depreciation model
Question 2(a)
• EPAT and NEA under 5y depreciation model
Question 2(b)
• The forecasts encompassing a 5y estimated life show the firm to be more profitable in 2017
• Why?
• Sales are the same under each approach; expenses are less under 5y approach
• Investment in plant and equipment is gradually increasing through 2017
• 5y life depreciates 1/5 of each of the past four years’ investment in 2017
• 3y life depreciates 1/3 of each of the past three years’ investment in 2017
Question 2(c)
• Calculations to show depreciation method does not affect intrinsic value of firm at the time of the IPO (early 2018)
Question 2(d)
• Despite your calculations, the founders insist the market will give a higher value if higher earnings are reported at the time of the IPO. What would be your reply to them?
• “I understand your viewpoint sir [or ma’am] (depending on gender of the founder making claim)…”
• Five-year depreciation would make earnings higher at the time of IPO
• But, the market places strong emphasis on future earnings potential in their valuation of a company
• The intrinsic value is the same under either approach
Question 2 (e)

The CFO suggests that the focus should be on profits in 2022 (year options vest). What arguments might be made to justify using one depreciation method over the other?

• The depreciation method does not affect intrinsic value
• Stock price should be same under each method
• But, some investors value stock based on earnings multiples
• In year of IPO (through 2021) expected earnings are greater if using a 5y depreciable life
• Should result in a higher stock price if using multiples
• Under 5y depreciable life, earnings will decrease from IPO (2018) through year stock options vest (2022)
• The earnings are identical under each depreciation method in 2022, but downward trend in earnings could decrease the stock price if uninformed investors presume the company is deteriorating
• It is best to use the depreciation period that most closely represents the assets’ useful economic life